Until now the standard was surgery, but it seems we are entering a new era where surgery could be avoided, says oncologist ...

Two of the world’s biggest drugmakers — AstraZeneca and MSD — have hailed progress in tackling hard-to-treat cancers, ...

From combining treatments in unprecedented ways to deploying artificial intelligence for personalised medicine, a raft of new ...

The surge in global cancer cases is raising serious concerns among experts. A recent study published in Monday in Cancer, a ...

OrigAMI-1 is the first study to show amivantamab plus chemotherapy may provide clinically meaningful benefits to patients with metastatic colorectal cancer who have not received any EGFR-targeted ...

A team of researchers at the University of Alberta has found that digoxin, a drug widely used to treat congestive heart ...

Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk ...

HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Sept. 19, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the Company , Stock Code: 2257 ...

Educational event for physicians by physicians; participants heard from an esteemed panel of experts, innovators, and guest speakers - - Global medtech leaders, Siemens Healthineers and Cook Medical, ...

Meet the Management at ESMO 2024 Conference September 16, 2024 2:00 PM ETCompany ParticipantsPascal Soriot - Chief ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...